Skip to main content


Yale Innovation Summit 2023

Biotech Track


The Biotech Track features 7 panels of nearly 50 leading venture investors and pharmaceutical industry executives discussing the venture investing environment in 2023, breakthrough technologies for drug discovery, and hottest new ideas for therapies to treat cancers, rare diseases, and other disorders.  Entrepreneurs will benefit from panels on how to pitch to investors and how to partner early with pharma. Investors will benefit from connecting with 60 biotech investment opportunities that will be presenting, ranging from pre-seed and seed stage to established late A, B, or C companies in the Connecticut Biotech Showcase.

Biotech Track Leader

New this year are biotech and digital health accelerator awards totaling $150K! Yale biotech and digital health innovators who submit their idea through Thumbraise will have an opportunity to be selected for one of 25 biotech ePoster slots and a chance to pitch onstage. A panel of venture capital judges will select the four most exciting ideas that are pitched to receive “Blavatnik Accelerator” award of $30K each. An additional $30K award will be made to the most exciting idea in the digital health pitch contest.

June 1, 2023

June 1, 2023: 8:30 - 8:45 am

BioCT: Time for Discovery

Meet BioCT's newly appointed President & CEO, Jodie Gillon, to hear about the organization's work to accelerate growth in the life sciences to improve human health, by fostering a rich, innovative ecosystem in Connecticut. 

Jodie Gillon brings over 25 years of experience in large pharma & biotech having started her career in advocacy and hospitals, in the US and abroad. With vast expertise leading key functions, she is sought after as an advisor to Incubators and Innovation Centers, and as a consultant for biotech, AI, RWE, digital health, and non profit organizations.
Jodie most recently served as the SVP of Corporate Affairs and Patient Advocacy building out the Patient, Medical, and Corporate Affairs functions at Peptilogics, a Phase I and Machine Learning start up. She previously served as the Chief Patient Officer and Head of Clinical Affairs Affairs at Abeona Therapeutics. Prior to joining Abeona, Jodie cumulatively spent over a decade with Pfizer as the Global Medical Lead, Patient Engagement, for the Rare Diseases Business Unit and the Director,
Medical Communications, within the Chief Medical Office.  Prior to Pfizer, Jodie held senior positions at Achillion Pharmaceuticals, AstraZeneca,  Novartis and Oridion Medical
She holds a Master’s of Public Health with a dual degree in Health Economics and Epidemiology from Hebrew University in Jerusalem and a BSFS from Georgetown’s School of Foreign Service. She currently serves on several industry wide Boards and Committees, has published and spoken externally across a wide variety of topics and mentors students and female professionals across our industry. 
June 1, 2023: 8:45 - 9:00 am

Meet the 2023 Blavatnik awardees


June 1, 2023 - 9:00 am - 12:00 pm

Connecticut biotech showcase

Presenting Companies

Block 1 (9:00-10:00)
Ancera (Arjun Ganesan)
Allyx (Tim Siegert)
AtlasXomics   (Ken Wang)
Azitra (Travis Whitfill)
Bexorg   (Zvonimir Vrselja)
Cellinfinity (Premal Patel)
Couragene   (Amy Liao)
Enrich Biosystems, Inc. (Dong Wang)

Block 2 (10:00-11:00)
Freedom Biosciences (Dina Burkitbayeva)
Modifi Bio (Ranjit Bindra)
Normunity (Rachel Humphrey)
Oova (Amy Divaraniya)
Osmol Therapeutics  (Bob Linke)
Pangolin Therapeutics  (Susan Froshauer)
Personal Therapeutics (Marc F. Pelletier)
Petragen David Kolb)
RigImmune  (Susan Sobolov)

Block 3 (11:00-12:00)
Proteowise Inc.  (Erik Gunther)

CCM Biosciences (Waj Mehal)
Sarxion Biologics  (Rocco Morelli)
Stradefy Biosciences (Sapan Shah)
Translura  (Siyuan Wang)
Veradermics  (Reid Waldman)
Entelion (Demetrios Braddock)
Felix Biotechnology (Paul Turner)
Gennao   (Chris Duke)

June 1, 2023 - 1:30 - 3:30 PM

Emerging Yale biotech showcase

Presenting Companies

Block 1 (1:30-2:30)
Apira (Joseph Contessa)
B3 Therapeutics (Mark Saltzman)
Curatix (Joseph Gennaro)
IntronX (Anna Pyle)
LKit Therapeutics (Ya Ha)
Luna Bioscience (Carla Devillers)
Panluminate (Ons M'Saad)
PanV (Mike Cola)

Block 2 (2:30-3:30)
RABET (Jaime Grutzendler)
Revalia Bio Inc. (Greg Tietjen)
Saga Bio (Ray Johnson)
Neurolexa Therapeutics (Angelique Bordey)
Targetsite (Ashoka Madduri)
Virtus Therapeutics (Choukri Ben Mamoun)
Methylzyme (Qin Yan)
RNAConnect (Ryan Muldoon)
D2B3(Anne Eichman)


June 1, 2023. 3:30 PM - 4:30 PM. 

Biotech pitch contest

14 of the most promising biotech projects will be competing for a live pitch spot and a chance at a Blavatnik Fund for Innovation at Yale accelerator award.